Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy
This study suggests that monitoring changes in immune biomarkers in the circulating cells of NSCLC patients may help differentiate CR/PR patients from SD/PD patients, providing a potential new approach for assessing the efficacy of chemotherapy combined with anti-PD-1 therapy.
Authors
- Shuang Xiao (ORCID: https://orcid.org/0000-0001-8171-0714)
- Tingting Lv (ORCID: https://orcid.org/0000-0001-5529-1851)
- Anyi Deng
- Chengjing Huang (ORCID: https://orcid.org/0000-0003-1794-4975)
- Jiawei Li (ORCID: https://orcid.org/0000-0001-7846-8963)
- Y Zhang (ORCID: https://orcid.org/0000-0001-5369-8877)
- Lu Bai
- Dongwei He (ORCID: https://orcid.org/0000-0003-2212-1973)
- Zhinan Yin (ORCID: https://orcid.org/0000-0001-6524-8777)
- L. Zhang (ORCID: https://orcid.org/0000-0001-6308-5038)
- Zheng Wu (ORCID: https://orcid.org/0000-0002-7355-0316)
- Zhiyu Wang (ORCID: https://orcid.org/0000-0002-5299-8410)
- Shenghu Guo
- Xinlu Guo
- Yong Xie (ORCID: https://orcid.org/0000-0001-9692-6593)
- Chunwang Yang
- Jing Cao (ORCID: https://orcid.org/0009-0004-4651-0505)
- Jiaxing Zhu (ORCID: https://orcid.org/0000-0001-6143-5807)
- Rui Zhang (ORCID: https://orcid.org/0000-0002-3045-9969)
- Li Xing (ORCID: https://orcid.org/0000-0002-4186-7909)
- Zhenghu Jia
- Ya Liu (ORCID: https://orcid.org/0009-0005-5866-3178)
Institutions
- Hebei Medical University (CN)
- Jinan University (CN)
- First People's Hospital of Foshan (CN)
- Fourth Hospital of Hebei Medical University (CN)
- First Affiliated Hospital of Xinxiang Medical University (CN)
- Jiangxi College of Applied Technology (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-04-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1521708
- Citations
- 6
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 6.27